3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
NIH
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
210
Breast Neoplasms
116
Neoplasms
111
Colorectal Neoplasms
94
Multiple Myeloma
87
Prostatic Neoplasms
83
Neoplasm Metastasis
71
Ovarian Neoplasms
69
Lung Neoplasms
67
Recurrence
57
Squamous Cell Carcinoma of Head and Neck
55
Pancreatic Neoplasms
47
Stomach Neoplasms
42
Leukemia, Lymphocytic, Chronic, B-Cell
41
Lymphoma, Large B-Cell, Diffuse
39
Small Cell Lung Carcinoma
38
Melanoma
37
Lymphoma, Non-Hodgkin
37
Leukemia, Myeloid, Acute
37
Parkinson Disease 4, Autosomal Dominant Lewy Body
36
Carcinoma, Renal Cell
36
Advanced Solid Tumors
35
Endometrial Neoplasms
34
Triple Negative Breast Neoplasms
29
Lymphoma, Follicular
29
Urinary Bladder Neoplasms
26
Head and Neck Neoplasms
26
Carcinoma, Hepatocellular
25
Myasthenia Gravis
23
Esophageal Neoplasms
23
Interventions
pembrolizumab
1
Pemetrexed
1
Cisplatin
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Pathologic Processes
×
30 days
×
Clear all
NCT06119581
2026-05-19
SUNRAY-01
Eli Lilly and Company
Phase 3
Recruiting
1,264 enrolled